Arzneiwerk AG VIDA (FRA: TLIK)
Germany
· Delayed Price · Currency is EUR 0.610
0.00 (0.00%)
At close: Dec 20, 2024
Arzneiwerk AG VIDA Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 59.68 | 59.28 | 73.37 | 2.52 | 2.82 | 4.16 | Upgrade
|
| Revenue Growth (YoY) | -1.96% | -19.21% | 2811.37% | -10.58% | -32.25% | -20.88% | Upgrade
|
| Cost of Revenue | 56.1 | 56.06 | 70.33 | 0.5 | 0.51 | 4.04 | Upgrade
|
| Gross Profit | 3.58 | 3.22 | 3.05 | 2.02 | 2.3 | 0.12 | Upgrade
|
| Selling, General & Admin | 1.9 | 2.17 | 2.8 | 1.48 | 1.63 | - | Upgrade
|
| Other Operating Expenses | 2.16 | 2.47 | 1.4 | 0.84 | 0.75 | -2.04 | Upgrade
|
| Operating Expenses | 5.08 | 5.65 | 20.74 | 2.34 | 2.4 | -2.02 | Upgrade
|
| Operating Income | -1.5 | -2.43 | -17.7 | -0.32 | -0.1 | 2.14 | Upgrade
|
| Interest Expense | -0.8 | -0.6 | -0.33 | -0 | -0.02 | -0.22 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | 0.01 | -0 | -0 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | 0 | 0.05 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2.3 | -3.02 | -18.02 | -0.27 | -0.11 | 1.92 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0 | 0.03 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 1 | 2.55 | Upgrade
|
| Pretax Income | -2.3 | -3.02 | -17.99 | -0.27 | 0.89 | 4.47 | Upgrade
|
| Income Tax Expense | -0.15 | -0.14 | -1.05 | 0 | 0.06 | 0.6 | Upgrade
|
| Earnings From Continuing Operations | -2.15 | -2.88 | -16.94 | -0.27 | 0.82 | 3.87 | Upgrade
|
| Earnings From Discontinued Operations | -0.05 | - | 0.31 | - | - | - | Upgrade
|
| Net Income | -2.2 | -2.88 | -16.64 | -0.27 | 0.82 | 3.87 | Upgrade
|
| Net Income to Common | -2.2 | -2.88 | -16.64 | -0.27 | 0.82 | 3.87 | Upgrade
|
| Net Income Growth | - | - | - | - | -78.69% | 249.91% | Upgrade
|
| Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 4 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 4 | 3 | Upgrade
|
| Shares Change (YoY) | - | - | - | 42.65% | 50.00% | - | Upgrade
|
| EPS (Basic) | -0.35 | -0.46 | -2.67 | -0.04 | 0.19 | 1.33 | Upgrade
|
| EPS (Diluted) | -0.35 | -0.46 | -2.67 | -0.04 | 0.19 | 1.33 | Upgrade
|
| EPS Growth | - | - | - | - | -85.80% | 249.91% | Upgrade
|
| Free Cash Flow | -2.58 | 0.07 | -0.69 | -0.33 | -1 | -0.66 | Upgrade
|
| Free Cash Flow Per Share | -0.41 | 0.01 | -0.11 | -0.05 | -0.23 | -0.23 | Upgrade
|
| Gross Margin | 6.00% | 5.44% | 4.15% | 80.19% | 81.78% | 2.96% | Upgrade
|
| Operating Margin | -2.52% | -4.10% | -24.12% | -12.72% | -3.39% | 51.47% | Upgrade
|
| Profit Margin | -3.69% | -4.86% | -22.67% | -10.61% | 29.26% | 93.03% | Upgrade
|
| Free Cash Flow Margin | -4.32% | 0.11% | -0.94% | -13.11% | -35.47% | -15.87% | Upgrade
|
| EBITDA | -0.78 | -1.71 | -1.55 | -0.29 | -0.08 | 2.16 | Upgrade
|
| EBITDA Margin | -1.30% | -2.88% | -2.11% | -11.59% | -2.70% | 51.89% | Upgrade
|
| D&A For EBITDA | 0.73 | 0.72 | 16.15 | 0.03 | 0.02 | 0.02 | Upgrade
|
| EBIT | -1.5 | -2.43 | -17.7 | -0.32 | -0.1 | 2.14 | Upgrade
|
| EBIT Margin | -2.52% | -4.10% | -24.12% | -12.72% | -3.39% | 51.47% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 7.00% | 13.35% | Upgrade
|
| Revenue as Reported | - | - | - | - | 4.18 | 10.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.